4Mandell L A, Wunderink R G, Anzueto A, et al. Infectious disea- ses society of America/American thoracic society consensus guide- lines on the management of community-acquired pneumonia in a- dults [J]. Clin Infect Dis, 2007, 44 Suppl 2:S27-72.
5Gomez-Junyent J, Garcia-Vidal C, Viasus D, et al. Clinical fea- tures, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease [ J ]. PloS One, 2014, 9(8) : e105854.
6Di Yacovo S, Garcia-Vidal C, Viasus D, et al. Clinical features, etiology, and outcomes of community-acquired pneumonia in pa- tients with diabetes mellitus [J]. Medicine, 2013, 92( 1 ): 42 - 50.
7Lozano R, Naghavi M, Foreman K , et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010 : a systematic analysis for the global burden of disease study 2010[J]. Lancet, 2013, 380(9859) :2095 - 128.
8Woodhead M. Community-acquired pneumonia in europe: causa- tive pathogens and resistance patterns [ J ]. Eur Respir J Suppl, 2002, 36:20s -27s.
9Zhan Y, Yang Z, Chen R, et al. Respiratory virus is a real patho- gen in immunocompetent community-acquired pneumonia: compa- ring to influenza like illness and volunteer controls[ J]. BMC Pulm Med, 2014, 14(1) :144.
10Peto L, Nadjm B, Horby P, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review [ J ]. Trans R Soc Trop Med Hyg, 2014, 108(6) : 326 -37.
